Method and device for non-invasive detection of pathogens in wounds
By using a system of nanosensor arrays and pattern recognition algorithms in wound infection detection, the problems of long detection time and low sensitivity in the prior art are solved, and early, real-time and accurate detection of wound infection is achieved, and diagnostic efficiency and accuracy are improved. .
Patent Information
- Application Number
- CN202380026632.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-12-20
- Filing Date
- 2023-03-07
- Publication Date
- 2024-11-08
Smart Images

Figure CN118922126A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application is a continuation-in-part of U.S. patent application Ser. No. 17 / 751,207, filed May 23, 2022, entitled “Non-invasive Device for Monitoring, Detecting, and Diagnosing Disease and Human Manifestations,” which claims priority to U.S. Provisional Patent Application Ser. No. 63 / 192,005, filed May 22, 2021, entitled “Non-invasive Wearable Smart Sensor for Rapid Monitoring, Screening, and Diagnosing Disease from the Skin,” U.S. Provisional Patent Application Ser. No. 63 / 192,006, filed May 22, 2021, entitled “Non-invasive Wearable / Portable Smart Sensor for Rapid Monitoring, Screening, and Diagnosing Disease from the Skin,” and U.S. Provisional Patent Application Ser. No. 63 / 269,151, filed March 10, 2022, entitled “Method and Apparatus for Real-Time Non-invasive Detection and Identification of Pathogens in Wounds.” The disclosures of the aforementioned patent applications are incorporated herein by reference in their entireties.
[0003] This application also claims priority to U.S. Provisional Patent Application No. 63 / 269,151, filed on March 10, 2022, entitled “Methods and Apparatus for Real-Time Non-Invasive Detection and Identification of Pathogens in Wounds,” and U.S. Provisional Patent Application No. 63 / 434,064, filed on December 20, 2022, entitled “Integrated Sensors in Negative Pressure Wound Devices for Wound Monitoring and Early Detection of Infection.” Technical Field
[0004] Embodiments of the present invention relate to the detection and identification of pathogens for real-time early detection of wound infection. Background Art
[0005] Discussion of prior art
[0006] Chronic skin wound infections and surgical site infections (SSIs) place a significant burden on the healthcare system in the United States and can lead to increased morbidity and mortality. Common pathogens associated with chronic, superficial, and deep SSIs include, but are not limited to, Staphylococcus epidermidis (SE), Streptococcus pyogenes (SP), Enterococcus faecalis (EF), Staphylococcus aureus (SA), Klebsiella pneumoniae (KP), Acinetobacter baumannii (AB), Pseudomonas aeruginosa (PA), Enterobacter spp. (ES), Escherichia coli (EC), Proteus mirabilis (PM), Serratia marcescens (SM), Enterobacter cloacae (E.cl), and Acinetobacter nitrosus (AA).
[0007] Negative pressure wound devices (NPWDs) are commonly used to treat wounds because they help remove excess fluid and promote healing. However, wounds can become infected, which can significantly delay healing and lead to serious complications if not treated properly. Early detection of wound infection is crucial to ensure timely treatment and optimal patient outcomes.
[0008] Current diagnostic methods for identifying and confirming infection include visual inspection, culture-based methods, and molecular methods. These techniques are time-consuming and resource-intensive, and some require sample transportation. The sensitivity and specificity of many of these techniques are also limited by sample handling and user error, requiring sophisticated laboratory science expertise and equipment.
[0009] Therefore, limitations of these methods can delay diagnosis, often leading to empirical treatment before the infecting pathogen is identified, which increases the risk of suboptimal antibiotic selection. This often leads to the development of antibiotic resistance and increased mortality. Furthermore, these methods may not provide real-time results, making it difficult to detect and treat infections promptly.
[0010] As a diagnostic tool, volatile organic compounds (VOCs) include a variety of carbon-based molecules, including alcohols, isocyanates, ketones, aldehydes, hydrocarbons, and sulfides, all of which are volatile at ambient temperatures. VOC testing has the advantages of being painless, non-invasive, and repeatable. Growing evidence suggests that VOCs and their combinations are specific to various disease states, and their early detection represents a useful diagnostic tool. VOCs have been identified as potential biomarkers for the diagnosis of lung cancer, breast cancer, asthma, and diabetes.
[0011] Pathogens also produce VOCs, and volatile gas detection through breath testing is now at the forefront of infection diagnosis. The ability to rapidly detect microbial VOCs allows for pathogen identification, which has had a significant impact on infection management in various settings, from triage and point-of-care in austere environments to hospital, clinic, and home settings. If a patient's wound can be accurately monitored from the early stages, through discharge, and into home use, appropriate antimicrobial therapy can be initiated early to prevent more serious infections, and infection status can be monitored continuously. Summary of the Invention
[0012] According to one embodiment of the present invention, a system is used to detect wound infection. The system includes at least one sensor and at least one processor. The at least one sensor detects one or more gases emitted by one or more pathogens that cause infection in the wound. The at least one sensor includes sensing materials that change one or more properties in response to the presence of the one or more gases. The at least one processor analyzes information from the at least one sensor to identify the one or more pathogens and determine whether an infection is present in the wound. The one or more pathogens are identified based on a pattern of changes in one or more properties indicative of the corresponding pathogens. In one embodiment, the at least one sensor is disposed in one of a wearable device, a portable device, and a wound dressing. In one embodiment, the system further includes a negative pressure source for applying negative pressure to the wound to promote healing. Some embodiments of the present invention also include a method and a device having a storage device containing software executable by at least one processor to detect wound infection in a manner substantially the same as described above. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Generally speaking, like reference numerals are used in the various figures to denote like components.
[0014] Figure 1 An exemplary wearable device according to one embodiment of the present invention is shown.
[0015] Figure 2 FIG. 1 is a schematic diagram showing various components of an apparatus according to an embodiment of the present invention.
[0016] Figure 3 A flow chart showing an exemplary method of preparing a sensing material for use in sensors in a sensor array according to an embodiment of the present invention.
[0017] Figure 4 Shown are TEM images of the sensing materials in an exemplary sensor array and their responses to VOC gases.
[0018] Figure 5 The process of building a model / classifier and using the model / classifier to diagnose wound infection according to one embodiment of the present invention is shown.
[0019] Figure 6A A portable device according to one embodiment of the present invention is shown.
[0020] Figure 6B An embodiment of the present invention uses Figure 6A The portable device is shown to detect infection in wounds.
[0021] Figure 7A and 7B Shows the use Figure 6A An example of using the device to analyze the VOC patterns of bacteria in wound infections, including Escherichia coli (E. coli), Pseudomonas aeruginosa (PA), and Staphylococcus aureus (SA).
[0022] Figure 8 A wearable device integrated into a dressing system for real-time monitoring of wound infection according to one embodiment of the present invention is shown.
[0023] Figures 9A to 9D Shown by Figure 8 An example of VOC patterns of pathogens from a wound infection detected by the wearable device is shown.
[0024] Figure 10A Sensor measurement results for an analyte in one exemplary embodiment of the present invention are shown.
[0025] Figure 10B Sensor data for an exemplary embodiment of the present invention projected into a set of principal components is shown.
[0026] Figure 10C Sensor data for an exemplary embodiment of the present invention projected into a set of different principal components is shown.
[0027] Figure 10D The accuracy of bacteria prediction for an exemplary embodiment is shown.
[0028] Figure 11 Another exemplary wearable device for detecting wound infection according to an embodiment of the present invention is shown.
[0029] Figure 12A A negative pressure wound device according to one embodiment of the present invention is shown.
[0030] Figure 12B Shows the use of an embodiment according to the present invention Figure 12A The case of the negative pressure wound device shown. DETAILED DESCRIPTION
[0031] One embodiment of the present invention can detect in real time whether an infection is present in a wound of a subject and identify whether one or more specific pathogens are present in the wound.
[0032] One embodiment of the present invention relates to a wearable or portable device or system comprising a sensor array having a plurality of sensors, a detection mechanism, and a pattern recognition analyzer, and to using the device or system to diagnose wound infection in a non-invasive, real-time manner.
[0033] The device of an embodiment of the present invention can be embedded in a wound dressing or near a wound. The device includes a MAC chip sensor array module, a microcontroller unit (MCU) module, a digital signal processing circuit (DSC), an analog-to-digital converter (ADC), a communication interface (USB, Bluetooth, and WiFi), an on-off switch, and a user interface. The sensor array module includes a sensor or multiple sensors based on multi-component nanostructured materials and combines pattern recognition and machine learning or other algorithms. The device can be used to provide convenient, non-invasive, real-time detection, and can detect all stages of infection from the early stages of wound infection, thereby enabling caregivers to provide effective and timely treatment.
[0034] Embodiments of the present invention can directly detect the development of infection in the wound bed and simultaneously identify active microorganisms for wound infection management in a hospital or other setting. Embodiments of the present invention provide a non-invasive technology that utilizes nanomaterial-based sensors to detect early infection stages before symptoms develop and provide continuous monitoring throughout all stages of infection.
[0035] As used herein, the singular forms "a," "an," and "the" include both the singular and the plural, unless the context clearly dictates otherwise.
[0036] The terms "optional" or "optionally" mean that the subsequently described event, circumstance or substituent may or may not occur, and that the description includes instances where the event or circumstance occurs and instances where it does not.
[0037] Numerical ranges defined by endpoints include all numbers and fractions within the respective ranges, as well as the listed endpoints.
[0038] As used herein, the terms "about" or "approximately" when applied to measurable values (e.g., parameters, quantities, lengths of time, etc.) are intended to include deviations from the specified value, such as ±10% or less, ±5% or less, ±1% or less, and ±0.1% or less, as applicable in the present disclosure. It should be understood that the value to which the modifier "about" or "approximately" refers is also explicitly disclosed.
[0039] The terms "subject," "individual," and "patient" are used interchangeably herein and refer to a vertebrate, preferably a mammal, most preferably a human. Mammals include, but are not limited to, rodents, apes, humans, farm animals, sports animals, and pets. They also include tissues, cells, and progeny of biological entities obtained in vivo or cultured in vitro.
[0040] The term "exemplary" as used herein means serving as an example, instance, or illustration. Any aspect or design described herein as "exemplary" is not necessarily to be construed as better or advantageous over other aspects or designs. Instead, the use of the word "exemplary" is intended to present concepts in a concrete manner.
[0041] It will be understood that when an element is referred to as being "on," "attached," "connected," "coupled," "in contact with," etc., another element, it can be directly on, attached to, connected to, coupled to, or in contact with the other element, and intervening elements may be present. In contrast, when an element is referred to as being "directly on," "directly attached," "directly connected," "directly coupled," or "directly in contact with" another element, for example, there are no intervening elements. Those skilled in the art will also understand that a structure or feature that is "adjacent" another feature may have portions that overlap or are located below the adjacent feature.
[0042] The term "real-time" is used to describe the process of sensing, processing, or transmitting information within a time frame equal to or shorter than the minimum timeframe for which the information is needed. For example, real-time monitoring of pulse rate might result in an average pulse rate measurement once per minute, averaged over 30 seconds, because instantaneous pulse rates are generally useless to the end user. Typically, averages of physiological and environmental information are more meaningful than instantaneous variations. Therefore, in certain embodiments of the present invention, signals may sometimes be processed over a period of several seconds or even minutes to produce a "real-time" response.
[0043] The terms "infection" and "bacterial infection" refer to the presence and / or colonization of pathogenic bacteria in the body or on a subject in sufficient numbers or amounts to cause disease, illness, damage, or injury to the subject infected with the bacteria. A subject that is infected is said to be "infected" with a pathogen. As used herein, "pathogenic bacteria" or its short form "pathogen" refers to bacteria known to cause a bacterial infection in a subject.
[0044] The terms "include," "comprising," and the like are used to indicate the presence of a stated element, step, operation, and / or component, but do not preclude the presence or addition of one or more other elements, steps, operations, and / or components. The terms "first," "second," and the like may be used to describe various elements, but do not limit these elements. These terms are simply used to distinguish one element from another.
[0045] Various embodiments are described below. It should be noted that the specific embodiments are not intended to be exhaustive or to limit the broader aspects discussed herein. An aspect described in conjunction with a particular embodiment is not necessarily limited to that embodiment, but may also be implemented in conjunction with any other embodiment. References in this specification to "one embodiment," "an embodiment," or "an exemplary embodiment" mean that a particular feature, structure, or characteristic associated with that embodiment is included in at least one embodiment of the present disclosure. Therefore, the phrases "in one embodiment," "in an embodiment," or "in an exemplary embodiment" appearing throughout this specification do not necessarily refer to the same embodiment, but may also refer to the same embodiment. Furthermore, as will be apparent to those skilled in the art from this disclosure, particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Furthermore, while some embodiments described herein include certain features from other embodiments but not other features, combinations of features from different embodiments are within the scope of this disclosure. For example, in the appended claims, any of the embodiments set forth may be used in any combination.
[0046] Embodiments of the present invention can be used to detect and identify wound infections using VOCs released by pathogens in a subject (e.g., on the skin of the palms, fingers, ears, nose, face, eyes, arms, legs, chest, breasts, back, abdomen, and / or feet), thereby enabling real-time monitoring of dynamic changes in VOCs. Smart nanosensors, combined with pattern recognition and machine learning algorithms, can enable early detection of wound infections.
[0047] The device of one embodiment of the present invention can be used for real-time detection and identification of pathogens in a subject. The device includes at least one sensor array, a microcontroller unit (MCU), a digital signal processing circuit (DSC), an analog-to-digital converter (ADC), a communication interface (USB, Bluetooth and WiFi) and an "on-off switch". The detection results are transmitted to a mobile phone or laptop in real time via wireless communication, and / or transmitted to a designated server for data analysis and storage. These devices are all equipped with a user interface. The information includes vital signs (such as skin temperature), VOC information, and environmental conditions (time, temperature, humidity and / or pressure). Based on the collected information, a comprehensive information library can be established to support pattern recognition and machine learning algorithms, thereby detecting wound infections early.
[0048] In one embodiment, a method or process for diagnosing wound infection includes: applying the device to or near a wound, such as attaching or embedding the device into a wound dressing system, wound healing system, or wound management system; using a nanostructured sensor array to detect metabolite VOC gases emitted from the wound in real time; analyzing electrical properties in response thereto; and using pattern recognition and machine learning algorithms to identify and characterize pathogens. Furthermore, the method may further include diagnosing infection and / or identifying bacteria in internal medicine, rheumatology, physical medicine, rehabilitation, clinical research, and basic research in the fields of immunology and / or microbiology; and evaluating the efficacy of drugs known to kill or inhibit the growth of bacteria causing the infection in subjects.
[0049] One embodiment of the present invention provides a wearable and / or portable device for rapid in vivo and in vitro pathogen screening and diagnosis. The device includes a housing with an open structure and at least one open end of the device disposed on the housing. The device includes a nanosensor and / or biosensor for detecting VOCs released by pathogens to obtain data. This data is provided to a remote server connected to the nanosensor and / or biosensor, which is then captured and processed within the device housing and transmitted to a data collection unit.
[0050] In certain embodiments, the device includes a sensor array module for detecting VOCs, sensors for monitoring vital signs (such as heart rate, blood pressure, respiratory rate, blood oxygen saturation, and / or skin temperature and / or body temperature), artificial intelligence / machine learning algorithms, and an intuitive, user-friendly interface.
[0051] Figure 1An example of a wearable device 100 for a user or subject according to one embodiment of the present invention is shown. Device 100 includes a top cover 105 with an indicator light 110, such as an OLED (or LCD display with which the user can interact), that displays device status; a bottom cover 115 with two cup-shaped inlets 120 adapted for connection to a surface of a test subject; and electronics 125 and a battery 130 housed between the top and bottom covers. The cup-shaped inlets allow VOCs originating from a wound site on the test subject to enter the device. The electronics include two sensor arrays 135, each with multiple sensors for detecting VOCs, and a chip containing electronic components for recording (e.g., in non-volatile memory), processing (e.g., via a processor), and transmitting (e.g., via a Bluetooth card 140, Wi-Fi card, etc.) the data. The battery provides power to the electronics. In this embodiment, the cup-shaped inlets on the bottom cover are connected to the sensor arrays in the electronics via conduits (e.g., tubing), allowing the sensor arrays to be immediately exposed to VOCs entering the inlets. The device has a strap 145 that can be secured to a limb or torso (e.g., hand, finger, ear, nose, face, eye, arm, leg, chest, breast, back, abdomen, and / or foot) of a person or mammal.
[0052] In certain embodiments, the inlet on the device is covered by a waterproof and / or breathable film. The sensor array includes a plurality of VOC sensors and one or more physiological sensors that react to the VOCs and generate a signal when exposed to gases, vapors, or odors containing VOCs released by pathogens in the subject's wound. The device may be integrated with a plurality of commercially available physiological sensors for monitoring vital signs. These vital signs may include heart rate, pulse, respiratory rate, blood oxygen saturation, blood pressure, hydration, pressure, body position and balance, body strain, neurological function, brain activity, blood pressure, intracranial pressure, auscultation information, skin temperature and body temperature, sleep, cholesterol, blood lipids, blood type, body fat density and / or muscle density. Other sensors may also be installed to monitor environmental conditions such as temperature, humidity, and / or pressure. The collected data can be used for pattern recognition and machine learning algorithms, which can be used to detect wound infection and perform other functions.
[0053] Figure 2 is a block diagram showing the components of a device 200 for detecting wound infection according to one embodiment of the present invention. The device 200 may correspond to any device described herein (e.g., Figure 1 、 6A, 6B, 8, 11, 12A and 12B). The device includes a sensor array 205 (which includes a plurality of VOC sensors), and optionally one or more physiological sensors and / or environmental sensors. The signals of the plurality of sensors are sent to the sensor signal processing circuit 210 for processing. The switch channel 215 selects the signal of one of the sensors at a time and sends it to one of the analog-to-digital converters (ADC) 220 to convert it into a digital signal. The digital signal enters the microcontroller unit (MCU) 230 through the serial peripheral interface (SPI) 225. The MCU 230 can be connected to a flash memory or RAM 235 for data storage and / or retrieval. In Figure 2 In the illustrated embodiment, MCU 230 is connected to MCU 240 via USB interface 245. MCU 240 is part of a communication module 250 that transmits processed output to adjacent devices via a communication device (e.g., a Bluetooth card or a WiFi card). Communication module 250 is also connected to its own flash / RAM memory 255, as well as a user interface (e.g., a liquid crystal display (LCD) 260, a capacitive touch screen (CTP) 265), and a switch 270.
[0054] The battery 275 and power management circuit 280 control the power supply to the sensor array and other electronic devices. It should be noted that the user can send commands through the user interface to control the sensor array 205. The device may also have embedded firmware that runs the device.
[0055] In certain embodiments, the raw or processed data detected by the sensor array 205 is wirelessly transmitted in real time to a mobile phone or laptop computer, and / or to a designated server for data analysis and storage. The transmitted data may include vital signs (such as heart rate, blood pressure, respiratory rate, blood oxygen saturation and / or skin temperature and / or body temperature), VOC information, and environmental conditions (time, temperature, humidity, and / or pressure). Based on the collected information, a comprehensive database can be established to support pattern recognition and machine learning algorithms, thereby enabling early detection of wound infections.
[0056] In some embodiments, the device measures VOCs based on a nanostructured sensor array. The sensor array includes a plurality of sensors, such as 2 to 6 to 8 to 12 to 32 or more sensors having a sensing material, each sensor comprising a material that changes some property, such as electrical resistance, when in contact with certain VOCs. The sensing material includes at least one or two or more or a mixture of nanoporous structures, such as mesoporous, macroporous, microporous, nanoporous, non-porous, hierarchically porous materials, including mesoporous / macroporous hierarchical structures, microporous / macroporous hierarchical structures, microporous / mesoporous hierarchical structures, microporous / mesoporous / macroporous hierarchical structures, and the like. The configuration of the mesoporous structure is selected from an ordered mesoporous structure with regular pore arrangement, a worm-like mesoporous structure with uniform pore size but no long-range regularity, or a disordered mesoporous structure with a pore size of 2-50 nm. The configuration of the macroporous structure is selected from an ordered macroporous structure or a disordered macroporous structure with a pore size between 50 nm and 50 μm. In another embodiment, the sensor material has a pore size range of 0.4 to 2 nm, 2 to 50 nm, 50 to 200 nm, 200 to 500 nm, 500 nm to 1 μm, 1 to 50 μm. The specific surface area is 1-1000 m 2 / g.
[0057] In some embodiments, the sensing material comprises a mono-, di-, ternary, quaternary, penta-, hexa-, hepta-, and octa-component metal oxide selected from the group consisting of tin (Sn), terbium (Tb), cobalt (Co), zinc (Zn), indium (In), copper (Cu), nickel (Ni), chromium (Cr), manganese (Mn), tungsten (W), titanium (Ti), vanadium (V), iron (Fe), aluminum (Al), gallium (Ga), silver (Ag), gold (Au), palladium (Pd), rhodium (Rh), ruthenium (Ru), molybdenum (Mo), niobium (Nb), zirconium (Zr), yttrium (Y), lanthanum (T), tungsten (W), tungsten (W), tungsten (W), tungsten (T ... (La), platinum (Pt), silicon (Si), cerium (Ce) and tellurium (Te), such as CoZnInSnOx, CuSnCoInOx, CoZnCrNiOx, SnTbCoOx, SnTbZnOx, CoTbInOx, CoNiTbOx, CoCeNiCuOx, ZnSnTeOx, CoZnInOx, CuSnInOx, CoCrNiOx, SnWLaOx, SnInLaCoOx, CoOx, CoTbOx, where the composition of each chemical element is different and x=0.01-1.
[0058] The sensor array (such as sensor array 205) includes at least one or two or three or four or eight or twelve or more gas sensors, which can be used to detect one or more gases in the metabolic gas mixture produced by pathogens of wound infection.
[0059] In some embodiments, the sensor further includes a substrate, and a plurality of electrodes located on the substrate.
[0060] In some embodiments, the sensor can be configured as a form selected from a capacitive sensor, a resistive sensor, a chemiresistive sensor, an impedance sensor, and a field effect transistor sensor. Each possibility represents a separate embodiment of the present invention. In an exemplary embodiment, the sensor is configured as a chemiresistive sensor.
[0061] In some embodiments, the sensor further comprises a detection mechanism comprising means for measuring a change in resistance, conductance, alternating current, frequency, capacitance, impedance, inductance, mobility, electromotive force, an optical property, or a threshold value of voltage. Each possibility represents a separate embodiment of the present invention.
[0062] In some specific embodiments, a sensor array is provided for diagnosing wound infection caused by pathogens in a subject, the sensor array having a plurality of sensors, such as 2 to 6 to 8 to 12 to 32 to 48 sensors, which are basically composed of at least two sensing materials, a substrate, a plurality of electrodes located on the substrate, and a detection mechanism.
[0063] In some embodiments, when the sensing material comes into contact with at least one VOC indicative of a wound infection, the conductivity between the electrodes changes, thereby providing a measurable signal indicative of a wound infection caused by pathogens such as Staphylococcus epidermidis, Streptococcus pyogenes, Enterococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., Escherichia coli, Proteus mirabilis, Serratia marcescens, Enterobacter cloacae, Acinetobacter nitrosus, Lactobacillus delbrueckii, Gardnerella vaginalis, and antibiotic-resistant strains.
[0064] The gas sensor may include a sensing material. In some examples, the sensing material includes at least one or two or more or mixed nanoporous structures, such as mesoporous, macroporous, microporous, nanoporous, non-porous, hierarchical porous materials, including mesoporous / macroporous hierarchical structure, microporous / macroporous hierarchical structure, microporous / mesoporous hierarchical structure, microporous / mesoporous / macroporous hierarchical structure, and the like. The configuration of the mesoporous structure is selected from an ordered mesoporous structure with regular pore arrangement, a worm-like mesoporous structure with uniform pore size but no long-range regularity, or a disordered mesoporous structure with a pore size of 2-50 nm. The configuration of the macroporous structure is selected from an ordered macroporous structure or a disordered macroporous structure with a pore size between 50 nm and 50 μm. In another embodiment, the pore size range of the sensor material is 0.4 to 2 nm, 2 to 50 nm, 50 to 200 nm, 200 to 500 nm, 500 nm to 1 μm, 1 to 50 μm. The specific surface area is 1-1000 m 2 / g.
[0065] The sensing materials of some embodiments of the present invention may be in the form of nanomaterials. Examples of nanomaterials include nanowires, nanorods, nanospheres, nanoporous materials, nanoplates, nanosheets, nanonets, nanotubes, nanocubes, hollow nanospheres, nanopolyhedra, and nanoscrolls, among others.
[0066] In some embodiments, the sensing material comprises a mono-, di-, ternary, quaternary, penta-, hexa-, hepta-, and octa-component metal oxide selected from the group consisting of tin (Sn), terbium (Tb), cobalt (Co), zinc (Zn), indium (In), copper (Cu), nickel (Ni), chromium (Cr), manganese (Mn), tungsten (W), titanium (Ti), vanadium (V), iron (Fe), aluminum (Al), gallium (Ga), silver (Ag), gold (Au), palladium (Pd), rhodium (Rh), ruthenium (Ru), molybdenum (Mo), niobium (Nb), zirconium (Zr), yttrium (Y), lanthanum (T), tungsten (W), tungsten (W), tungsten (W), tungsten (T ... (La), platinum (Pt), silicon (Si), cerium (Ce) and tellurium (Te), such as CoZnInSnOx, CuSnCoInOx, CoZnCrNiOx, SnTbCoOx, SnTbZnOx, CoTbInOx, CoNiTbOx, CoCeNiCuOx, ZnSnTeOx, CoZnInOx, CuSnInOx, CoCrNiOx, SnWLaOx, SnInLaCoOx, CoOx, CoTbOx, where the composition of each chemical element is different and x=0.01-1.
[0067] In some embodiments, the sensing material comprises mono-, di-, ternary, quaternary, penta-, and hexa-element single-component or multi-component primary metal nanoparticles selected from the group consisting of silver (Ag), gold (Au), palladium (Pd), rhodium (Rh), ruthenium (Ru), platinum (Pt), osmium (Os), and iridium (Ir). The size of the nanoparticles ranges from 0.5 to 500 nm. The nanoparticles can be shaped like nanospheres, nanorods, nanowires, nanodots, nanostars, nanosheets, nanoplates, nanotubes, hollow nanospheres, nanocubes, or nanopolyhedrons. Some examples include platinum nanospheres, gold nanodots, silver nanowires, silver-gold nanocubes, and osmium nanorods.
[0068] In some embodiments, the sensing material comprises a carbon-based material. The carbon-based material may include carbon black, activated carbon, microporous carbon, mesoporous carbon, micro-mesoporous carbon, pyrolytic carbon, carbon nanotubes, carbon nanofibers, carbon nanospheres, carbon nanosheets, carbon nanowires, carbon nanorods, graphene, graphene oxide, and reduced graphene oxide. The carbon-based material may be doped with sulfur, nitrogen, oxygen, boron, fluorine, phosphorus, selenium, chlorine, and the like.
[0069] In some embodiments, the sensing material may comprise a carbon material functionalized with an organic agent such as amines, fatty acids, alcohols, thiols, aldehydes, phenols, esters, epoxies, polymers, silane coupling agents, and mixtures thereof.
[0070] In some embodiments, the sensing material may comprise a carbon material containing a single-atom metal in its carbon framework. The single-atom metal may be selected from the group consisting of tin (Sn), terbium (Tb), cobalt (Co), zinc (Zn), indium (In), copper (Cu), nickel (Ni), chromium (Cr), manganese (Mn), tungsten (W), titanium (Ti), vanadium (V), iron (Fe), aluminum (Al), gallium (Ga), silver (Ag), gold (Au), palladium (Pd), rhodium (Rh), ruthenium (Ru), molybdenum (Mo), niobium (Nb), zirconium (Zr), yttrium (Y), lanthanum (La), platinum (Pt), silicon (Si), cerium (Ce), tellurium (Te), osmium (Os), and iridium (IR).
[0071] In some embodiments, the sensing material includes metals and metal oxides as components that form a composite sensing material with the metal nanoparticles and the metal oxide.
[0072] In some embodiments, the sensing material includes a carbon-based material as a component forming a composite sensing material with metal nanoparticles and metal oxides.
[0073] In some embodiments, the sensing material includes a conjugated polymer, such as polythiophene material, polyaniline material, polypyrrole material, polycarbazole material, etc. In some embodiments, the conjugated polymer is mixed with a carbon-based material.
[0074] Figure 3A flow chart of an exemplary method 300 for preparing a sensing material for a sensor in a sensor array (e.g., forming a three-dimensional macroporous / mesoporous material array) is shown. In step 305, a pore-forming template solution is prepared using one or a mixture of two or more of polymer nanospheres, carbon black, carbon nanotubes, carbon nanofibers, carbon nanospheres, polymethyl methacrylate (PMMA) microspheres, polystyrene nanospheres, latex spheres, inorganic nanoparticles, silica nanoparticles, carbon nanoparticles, carbon dots, carbon nanocells, or a polymer, along with an amphoteric solvent. In step 310, a precursor solution is prepared using one or a mixture of two or more of metal species, graphene oxide, MXene, carbon nanotubes, metal nanoparticles, oligomeric organosilicon (1,4-bis(triethoxysilyl)benzene, 1,2-bis(triethoxysilyl)ethane, bis[(3-triethoxysilyl)propylamine(amine), ethyltriethoxysilane), along with an amphoteric solvent to produce a target product. In step 315, each precursor solution and pore-forming template solution is input as a separate solution into a separate channel of a deposition apparatus. In step 320, different proportions of each separate solution are deposited onto a substrate to generate synthetic thin films of different combinations and compositions at a point in the array. Each point has an independent composition of at least one precursor solution and at least one pore-forming template solution. In step 325, the amphoteric solvent is evaporated, and the composite meso / macro structure is formed into a synthetic thin film array. In step 330, the synthetic thin film array is heated to remove the organic pore-forming template, and / or the thin film array is treated with an aqueous NaOH or HF solution to remove the silica template, thereby generating a three-dimensional material array with macroporous and mesoporous structures.
[0075] Figure 4 Shown are exemplary TEM images of the sensing materials in the sensor array and their responses to VOC gases.
[0076] One embodiment of the present invention can detect and identify wound infections caused by pathogens in subjects. A method (for example, performed by a device as described herein) includes providing a sensor array comprising a plurality of sensors, for example, 2 to 6 to 8 to 12 to 32 sensors, wherein the sensor comprises at least one or two or more or mixed nanoporous structures, such as mesoporous, macroporous, microporous, nanoporous, non-porous, hierarchically porous materials, including mesoporous / macroporous hierarchical structures, microporous / macroporous hierarchical structures, microporous / mesoporous hierarchical structures, microporous / mesoporous / macroporous hierarchical structures, and the like. The configuration of the mesoporous structure is selected from an ordered mesoporous structure with regular pore arrangement, a worm-like mesoporous structure with uniform pore size but no long-range regularity, or a disordered mesoporous structure with a pore size of 2-50 nm. The configuration of the macroporous structure is selected from an ordered macroporous structure or a disordered macroporous structure with a pore size between 50 nm and 50 μm. In another embodiment, the sensor material has a pore size range of 0.4 to 2 nm, 2 to 50 nm, 50 to 200 nm, 200 to 500 nm, 500 nm to 1 μm, 1 to 50 μm. The specific surface area is 1-1000 m 2 / g.
[0077] The sensing material includes a mono-, di-, ternary, quaternary, penta-, hexa-, hepta- and octa-component metal oxide selected from the group consisting of tin (Sn), terbium (Tb), cobalt (Co), zinc (Zn), indium (In), copper (Cu), nickel (Ni), chromium (Cr), manganese (Mn), tungsten (W), titanium (Ti), vanadium (V), iron (Fe), aluminum (Al), gallium (Ga), silver (Ag), gold (Au), palladium (Pd), rhodium (Rh), ruthenium (Ru), molybdenum (Mo), niobium (Nb), zirconium (Zr), yttrium (Y), lanthanum (La). , platinum (Pt), silicon (Si), cerium (Ce) and tellurium (Te), such as CoZnInSnOx, CuSnCoInOx, CoZnCrNiOx, SnTbCoOx, SnTbZnOx, CoTbInOx, CoNiTbOx, CoCeNiCuOx, ZnSnTeOx, CoZnInOx, CuSnInOx, CoCrNiOx, SnWLaOx, SnInLaCoOx, CoOx, CoTbOx, where the composition of each chemical element is different, x = 0.01-1.
[0078] The sensor array is exposed to a metabolic gas mixture produced by pathogens of a wound infection in a subject. A detection mechanism is used to measure and analyze the response parameters of the sensors in the sensor array when exposed to the test VOC to generate a response pattern. The response pattern is analyzed together with a reference signal obtained from a control sample. Pattern recognition and machine learning algorithms are used to identify and identify pathogens. Infections can be diagnosed and / or bacteria can be identified in internal medicine, rheumatology, physical medicine, rehabilitation, clinical research, and basic research in the fields of immunology and / or microbiology. In cases where a drug is known to kill or inhibit the growth of bacteria causing the infection, the efficacy of the drug on the subject can be evaluated.
[0079] In some embodiments, measuring the plurality of response parameters includes measuring, extracting, filtering, amplifying, and processing the plurality of electrical signals from the sensors.
[0080] In some embodiments, the response inducing parameter is selected from the group consisting of: a normalized change in the sensor signal at peak exposure, a normalized change in the sensor signal at mid-exposure, a normalized change in the sensor signal at end-exposure, and an area under the curve of the sensor signal.
[0081] Pattern recognition and machine learning algorithms are applied to train the data and generate correlations between certain infection problems and signal patterns. These algorithms include at least one selected from the following: artificial neural network algorithms (such as Naif Bayes), principal component analysis (PCA), support vector machine (SVM), multi-layer perception (MLP), generalized regression neural network (GRNN), fuzzy inference system (FIS), self-organizing map (SOM), radial bias function (RBF), genetic algorithm (GAS), neuro-fuzzy system (NFS), adaptive resonance theory (ART), partial least squares (PLS), multiple linear regression (MLR), principal component regression (PCR), discriminant function analysis (DFA), linear discriminant analysis (LDA), cluster analysis and nearest neighbor analysis. In one embodiment, the at least one algorithm is principal component analysis (PCA).
[0082] Once the model is established, the system can generate early diagnostic results for wound infection using VOC patterns (and optionally vital signs and / or environmental conditions) as input.
[0083] The pathogens of wound infection include one or more bacteria or fungi, but are not limited to: Acinetobacter nitrogenadensis, Acinetobacter baumannii, Actinomyces ilbergii, Agrobacterium radiobacterium, Agrobacterium tumefaciens, Anaplasma phagocytophilum, Rhizobium stem-nodularis, Azotobacter vinelandii, Bacillus anthracis, Brevibacterium, Bacillus cereus, Bacillus fuscae, Bacillus licheniformis, Bacillus megaterium, Bacillus mycoides, Bacillus stearothermophilus, Bacillus subtilis, Bacillus thuringiensis, Bacteroides fragilis, Bacteroides gingivalis, Bacteroides melaninogenicus, Bartonella henselae, Bartonella quinquefasciatus, Bordetella bronchiseptica, Borrelia pertussis, Borrelia burgdorferi, Brucella abortus, Brucella melitensis, Brucella suis, Burkholderia mallei, Burkholderia pseudomallei, Burkholderia cepacia, Bacillus granulomatis, Campylobacter coli, Campylobacter fetus, Campylobacter jejuni, Helicobacter pylori Campylobacter, Chlamydia trachomatis, Chlamydia pneumoniae, Chlamydia psittaci, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae, Clostridium spp., Cook's fever bacillus, Ehrlichia chaffeensis, Enterobacter cloacae, Enterococcus avium, Enterococcus durconium, Enterococcus faecalis, Enterococcus faecium, Enterococcus gallinarum, Enterococcus maloratus, Escherichia coli, Fusarium tularensis, Bacillus nuclei, Enterobacter spp., Gardnerella vaginalis, Haemophilus ducreyi, Haemophilus influenzae, Haemophilus parainfluenzae, Haemophilus pertussis, Haemophilus vaginalis, Helicobacter pylori, Klebsiella pneumoniae, Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus delbrueckii, Lactococcus lactis, Legionella pneumophila, Listeria monocytogenes, Methanobacterium extroquens), Microbacterium pyogenes, Micrococcus luteus, Moraxella catarrhalis, Morganella morganii, Mycobacterium avium, Mycobacterium bovis, Mycobacterium diphtheriae, Mycobacterium intracellulare, Mycobacterium leprae, Mycobacterium leprae murine, Mycobacterium phlei, Mycobacterium smegmatis, Mycobacterium tuberculosis, Mycoplasma fermentans, Mycoplasma genitalium, Mycoplasma hominis, Mycoplasma penetrantis, Mycoplasma pneumoniae, Mycoplasma mexican, Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Pasteurella tularensis, Purple bacillus gingivalis, Prevotella melanogaster, Proteus vulgaris, Proteus mirabilis, Proteus penetrans, Providencia stuartii, Pseudomonas aeruginosa, Pseudomonas aeruginosa, Rhizobium radiobacterium, Rickettsia prowazekii, Rickettsia psittaci, Rickettsia quinquefasciatus, Rickettsia rickettsii, Rickettsia trachomatis, Rochalimaea henselae), RochalimaeaQuintana), Roseburia dentata, Salmonella enteritidis, Salmonella typhi, Salmonella typhimurium, Serratia marcescens, Shigella dysenteriae, Spirillum spirochetes, Staphylococcus aureus, Staphylococcus epidermidis, Stenotrophomonas maltophilia, Streptococcus agalactiae, Streptococcus avium, Streptococcus bovis, Streptococcus hamsteris, Streptococcus facialis (Streptococcus faceium), Streptococcus faecalis, Streptococcus muris, Streptococcus machine, Streptococcus lactis, Streptococcus mitis, Streptococcus mitis, Streptococcus mutans, Streptococcus oralis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus rats, Streptococcus salivarius, Streptococcus sanguinis, Streptococcus sobrinus, Treponema pallidum, Treponema denticola, Vibrio cholerae, Vibrio comma, Vibrio parahaemolyticus, Vibrio vulnificus, Yersinia enterocolitica, Yersinia pestis and Yersinia pseudotuberculosis, and / or known to contain one or more antibiotic-resistant strains (derived from known bacterial species), and / or known to contain one or more strains producing expanded-spectrum β-lactamases (derived from known bacterial species), in particular, the one or more strains producing expanded-spectrum β-lactamases are selected from the group consisting of: Escherichia coli producing expanded-spectrum β-lactamases and Klebsiella pneumoniae producing expanded-spectrum β-lactamases.
[0084] The antibiotic-resistant bacterial strain is selected from the group consisting of: carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, vancomycin-resistant Enterococcus faecalis, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Staphylococcus aureus, clarithromycin-resistant Helicobacter pylori, fluoroquinolone-resistant Campylobacter coli, fluoroquinolone-resistant Campylobacter fetus, fluoroquinolone-resistant Campylobacter jejuni, fluoroquinolone-resistant Campylobacter Helicobacter pylori, fluoroquinolone-resistant Salmonella Enteritidis, fluoroquinolone-resistant Salmonella typhi, fluoroquinolone-resistant Salmonella typhimurium, cephalosporin-resistant Neisseria gonorrhoeae, fluoroquinolone-resistant Neisseria gonorrhoeae, penicillin-nonsusceptible Streptococcus pneumoniae, ampicillin-resistant Haemophilus influenzae, fluoroquinolone-resistant Quinolone-resistant Shigella dysenteriae, carbapenem-resistant Escherichia coli, carbapenem-resistant Klebsiella pneumoniae, carbapenem-resistant Enterobacter cloacae, carbapenem-resistant Serratia marcescens, carbapenem-resistant Proteus vulgaris, carbapenem-resistant Proteus mirabilis, carbapenem-resistant Proteus pentaphylococcus, carbapenem-resistant Providencia stuartii, carbapenem-resistant Morganella morganii, cephalosporin-resistant Escherichia coli, cephalosporin-resistant Klebsiella pneumoniae, cephalosporin-resistant Enterobacter cloacae, cephalosporin-resistant Serratia marcescens, cephalosporin-resistant Proteus vulgaris, cephalosporin-resistant Proteus mirabilis, cephalosporin-resistant Proteus pentaphylococcus, cephalosporin-resistant Providencia stuartii, and cephalosporin-resistant Morganella morganii.
[0085] Figure 5is a flow chart showing a method 500 for diagnosing wound infection using VOC data (e.g., for a wearable / portable device 505). First, in step 510, a sufficient number of data samples are collected from healthy individuals (clean wounds) and patients with a known health condition (wound infection) (i.e., a discovery group). The data samples include VOC data patterns or VOC data patterns along with vital signs and / or environmental conditions. In steps 525, 530, 535, and 540, a mathematical algorithm is used to train the data, identify distinct patterns between healthy controls and patients, and develop a classifier. The mathematical algorithm can be one or more of PCA, Naif's Bayes, support vector machine (SVM), multi-layer perceptron (MLP), generalized regression neural network (GRNN), fuzzy inference system (FIS), self-organizing map (SOM), radial bias function (RBF), genetic algorithm (GAS), neuro-fuzzy system (NFS), adaptive resonance theory (ART), partial least squares (PLS), multiple linear regression (MLR), principal component regression (PCR), discriminant function analysis (DFA), linear discriminant analysis (LDA), cluster analysis, and nearest neighbor analysis. The classifier is preferably a machine learning model, but can also be a mathematical equation that predicts a portion of the vital signs of wound infection and / or skin (or pathogen)-VOCs.
[0086] In the discovery group, part of the data is randomly assigned to the training set in step 515, and the remaining data is assigned to the test set in step 520. Use the test set to develop the best classifier in the training set. Determine the value of the area under the ROC curve (AUC) in the patient. Then, the assessment device is directed to the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of the training set and the test set. For example, 5 times cross validation (randomly extracting 1 times of samples for testing and the remaining 4 times for training) can be used to calculate the classification performance of the training set.
[0087] Once the mathematical model (also known as a classifier) is developed in step 545, one or more independent clinical cohorts are collected to validate the model. During this process, the model parameters are continuously refined (in steps 525, 530, 535, and 540), and patients can be further stratified into subtypes using different sets of parameters. After the model is validated and refined, the user can input the subject's VOC data, vital signs, or both (and optionally environmental conditions) into the model / classifier, and the model can predict the health condition (or wound infection) in step 550.
[0088] Figure 6A and 6BAn exemplary portable device and method of use thereof according to one embodiment of the present invention are shown. The portable device 600 includes a handle 630 connected to the bottom of a processing device (e.g., a personal digital assistant (PDA) 620). The portable device comprises a disposable suction cup 605 adapted to cover the surface of a subject, a fan 610 adapted to create a slight vacuum in the suction cup 605, at least one sensor array module 615, and a PDA 620 with a user-interactive interface. The sensor array module 615 is similar to the aforementioned modules (e.g., sensor array 205). It comprises at least one sensor array, at least one sensor signal processing circuit, at least one switch channel circuit, at least one analog-to-digital converter (ADC), at least one microcontroller unit (MCU), at least one power management system, and at least one USB port. The signal processing circuit may include a voltage divider circuit for measuring the resistance of each sensor in the sensor array. To ensure ADC accuracy, multiple ADCs and switch channels may be used for data acquisition and digitization. The MCU collects the digital signals from the ADCs and transmits them to a system-on-chip (SoC) on the PDA 620.
[0089] The sensor array module 615 is attached to the suction cup 605. Using the suction cup 605 reduces environmental interference, such as hand sweat, dust, and temperature fluctuations. To enhance the device's sensitivity, a fan 610 is used to create a slight negative pressure in the suction cup, allowing most of the VOCs emitted from the palm of the hand to enter the portable device. The PDA 620 contains a system-on-chip (SoC) with I / O / wireless / USB communication capabilities, a central processing unit (CPU), memory, and an OLED or LCD screen. Data can be transmitted to a terminal (such as a PC) or a cloud database via a USB cable or wireless communication. The PDA runs an app that provides a human-machine interface, test data collection, and data transmission for further analysis. Test results can be displayed numerically on the PDA, or more intuitively using color-coded information (e.g., white for a value of 0 indicates a blank; green for a value of 0.1-2.9 indicates a healthy value (no infection); yellow for a value of 3-4.9 indicates continued testing; and red for a value exceeding 5.0 indicates an alert). For example, when a value exceeds 5.0, the PDA displays a red message to alert the user.
[0090] The device 600 can have many variations. For example, the device may not have a fan to draw the vacuum, but instead rely on diffusion. In addition, the device can be handheld or fixed. In some embodiments, the device has a pressure sensor that detects changes in ambient pressure and turns the device on from standby mode to working mode. Thus, when a part of the subject's body (such as a hand or forehead) covers the suction cup 605, the change in pressure can switch the device to working mode. In one embodiment, the device can automatically shut down when the data is sufficient to be read or after a predetermined time has passed in standby mode. The device may have a manual input option whereby the user can manually set the test time, for example 0.001-30 minutes. In addition, a health management system can be installed on a remote device (such as a server or smartphone) to analyze and visualize the sensor readings.
[0091] Figure 7A and 7B Shown is an analysis of VOC patterns detected using a portable device 600 for monitoring the growth of three bacteria in wound infections: Escherichia coli (E. coli), Pseudomonas aeruginosa (PA), and Staphylococcus aureus (SA). Each dot represents the device reading of VOCs in one primary space.
[0092] Figure 8 An exemplary embodiment of a wearable device 850 for real-time monitoring of wound infection is shown. Wearable device 850 is integrated into a dressing system 800 for detecting, identifying, and monitoring bacteria that can cause wound infection. Dressing system 800 includes a wound dressing 810 for covering a wound, and a wearable device 850 coupled to the wound dressing and positioned over or near the wound.
[0093] With reference Figure 1 or Figure 2 Similar to the description, the wearable device 850 has a sensor array, a sensor signal processing circuit (voltage divider circuit), a 4-channel switching circuit, four 14-bit analog-to-digital converters (ADCs), a microcontroller unit (MCU), and a USB interface. The sensor array may include a 3x3 array of 9 different gas sensors and a physiological sensor (skin temperature sensor). Each of the 9 sensors has a different nanostructured multi-component metal oxide, or a different amount (such as concentration) of nanostructured multi-component metal oxide composition or component. The voltage divider circuit is used to process the characteristic changes (such as voltage changes, resistance changes, impedance changes, and combinations thereof) of each sensor in the sensor array. To ensure ADC accuracy, 4 ADCs and 4-channel switching circuits can be used for data acquisition and digitization.
[0094] The MCU collects digital signals from the ADC and transmits them to the system. Data is transmitted wirelessly to a personal computer and cloud database. The controller unit includes an 8-bit microcontroller with a Wi-Fi communication module, a liquid crystal display (LCD), a capacitive touch screen (CTP), and an on-off switch. The communication unit sends and receives radio waves of a certain frequency. The communication and power supply module (rechargeable battery) contains the power supply and is also responsible for data acquisition and transmission. It can also connect to a personal computer via the Wi-Fi communication module. The CTP and LCD provide a human-computer interface.
[0095] The wearable device 850 continuously detected VOCs released by ESKAPEE pathogens (Enterococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) over a 36-hour period. All 16 sensors had complete profiles in all experiments.
[0096] Figures 9A-9D The data shows measurements from 16 sensors over a 36-hour period for four analytes (Enterococcus faecalis, Klebsiella pneumoniae, Acinetobacter baumannii, and Enterobacter spp.). Each ESKAPEE pathogen was distinguishable by a unique pattern within the first 12 hours. To advance AI-driven detection, a nine-class support vector machine (SVM) classifier was constructed to discriminate between sensor profiles of bacterial strains. To avoid overfitting artifacts, the SVM model was trained using 75% of the sample data set (sampled from the sensor profiles every half hour). The remaining 25% of the sample data served as a test set to validate the SVM model. The average accuracy for each bacterium was very high, reaching an overall accuracy of 97.08%.
[0097] Another exemplary embodiment shows the detection and identification of seven bacteria in wound infections. Figures 10A-10D The device and PCA analysis are used to distinguish common wound infection pathogens, including Enterococcus faecalis (EF), Staphylococcus aureus (SA), Klebsiella pneumoniae (KP), Acinetobacter baumannii (AB), Pseudomonas aeruginosa (PA), Enterobacter (ES) and Escherichia coli (EC), i.e., ESKAPEE bacteria. Each point represents the sensor array reading of the bacteria in the main space. Before qualitative analysis of VOCs emitted by the organisms in the early stage, each ESKAPEE bacterium was cultured on a separate LB-agar plate for 24 hours. Culture medium on a Luria broth (LB) agar plate without bacteria was used as a negative control for background signal. The culture was continuously measured for 48 hours using a MAC chip array. Measurements of a 5:5 mixed PA-SA strain and an empty plate were also included. Artificial intelligence algorithms were applied to separate the signals of individual strains into clearly identifiable groups.
[0098] The device of this embodiment uses a nanocomposite MAC chip sensor array consisting of 32 sensors. The MAC chip sensor array integrates three types of sensors manufactured by a high-throughput three-dimensional nanoprinting process, in which 200 different customized inks are used. These three types of sensors (and inks) use macroporous, mesoporous, microporous macroporous / mesoporous nanocrystal (MAC) films embedded in metal oxides, MAC embedded in graphene and nanoparticles, and carbon black and conductive polymer composites. The sensor materials have different and complementary sensing properties. The sensors are designed to easily absorb chemical vapors, and after chemical binding, the electrical properties of the sensors change, thereby generating a signal. Software with artificial intelligence algorithms can evaluate the presence / pattern of specific chemical pathogen odors and provide the results to patients and / or caregivers.
[0099] Sensing materials (e.g., CoZnInSnOx, CuSnCoInOx, CoZnCrNiOx, SnTbCoOx, SnTbZnOx, CoTbInOx, CoNiTbOx, CoCeNiCuOx, ZnSnTeOx, CoZnInOx, CuSnInOx, CoCrNiOx, SnWLaOx, SnInLaCoOx, CoOx, CoTbOx, where the composition of each chemical element varies, x = 0.01-1) form a conductive path between electrodes, thereby generating sensors in the MAC chip sensor array. For quaternary metal oxides, the molar ratios of the elements are 1:1:1:1, 1:1:0.5:0.5, 0.5:0.5:1:1, 0.1:0.1:1:1, and 1:1:0.1:0.1. For the ternary metal oxides, the molar ratios of each element are 1:1:1, 1:0.5:0.5, 1:0.1:0.1, 0.5:0.5:1, 0.1:0.1:1, and 0.1:1:0.1. The pore size of the multi-components is 2-100 nm.
[0100] VOCs from laboratory strains representing all ESKAPEE bacteria, mixed cultures, and empty LB agar plates were monitored continuously for 48 hours. All 19 sensors had complete profiles in all experiments. Figure 10A The images show measurements of nine analytes from 19 sensors over an 18-hour period. In a hierarchical clustering heatmap, bacterial profiles tend to cluster, with each bacterium exhibiting a unique pattern. These patterns were visualized using principal component analysis (PCA), which compresses high-dimensional data into lower dimensions while preserving the greatest variation. Figure 10B and 10CThe entire sensor data set (19 sensors, 7 bacterial species, PA-SA mixed bacteria, blank plates, and a 0.5-hour sampling interval) was projected onto two principal components (PC1 and PC2) and (PC1 and PC3). Each ESKAPEE bacterial species, mixed culture, and blank plate were distinguished by unique patterns within the first hour, with only a few clusters (e.g., EC and EF) partially overlapping.
[0101] To advance AI-driven detection, a 9-level support vector machine (SVM) classifier was constructed to discriminate sensor curves of 7 bacterial strains, PA-SA mixed strains, and empty plates. To avoid the illusion of overfitting, the dataset (804 samples of 7 bacteria, mixed strains, and empty plates were sampled from the sensor curves every half hour) was randomly divided into a training set (75% of the samples) and a test set (25% of the samples). The SVM model was trained on the training set and validated using the test set. After feature selection, 9 optimal features were extracted from 32 sensors. The prediction accuracy of each bacterial strain was recorded, and the process was repeated 10,000 times. The average accuracy for each bacterium was very high, and the overall accuracy reached 97.08% ( Figure 10D ).
[0102] Figure 11 Another embodiment of a wearable device 1100 for real-time monitoring is shown. In this example, the wearable device 1100 is a wearable wristwatch. The wearable device 1100 includes a sensor array, a sensor signal processing circuit (voltage divider circuit), a 4-channel switch circuit, an analog-to-digital converter (ADC), a microcontroller unit (MCU), and a USB interface as part of the electronic device 1125 (similar to Figure 1 or Figure 2 For example, the sensor array includes two different gas sensors and a physiological sensor (heart rate sensor). Each of the two sensors has a different nanostructured multi-component metal oxide, or a different amount (e.g., concentration) of the nanostructured multi-component metal oxide composition or ingredient.
[0103] The voltage divider circuit is used to process the electrical changes of each sensor in the sensor array (such as voltage changes, resistance changes, impedance changes, and their combinations). The MCU collects digital signals from the ADC and transmits them to the system. The data is analyzed using artificial intelligence algorithms and transmitted wirelessly to a personal computer and / or cloud database. The controller unit includes an 8-bit microcontroller with a WiFi communication module, a liquid crystal display (LCD) 1130, a capacitive touch screen (CTP) 1135, and an "on-off switch". The communication and power module (such as a rechargeable battery) 1140 contains a power supply and is also responsible for data acquisition and transmission. It can be connected to a personal computer via a Wi-Fi communication module. The CTP and / or LCD can provide a human-computer interaction interface.
[0104] In some embodiments, a negative pressure wound device may include the above-described device for detecting wound infection and may be used for negative pressure wound therapy.
[0105] Negative pressure wound therapy (NPWT) is a treatment modality that involves using a device to apply negative pressure to a wound dressing to promote wound healing and reduce the risk of infection. NPWT has been shown to be effective for a variety of wound types, including chronic wounds, traumatic wounds, and surgical wounds.
[0106] Despite the many benefits of NPWT, wound infection remains a common complication of this therapy. Wound infection can delay healing and may require additional treatment, such as antibiotics.
[0107] Therefore, one embodiment of the present invention provides a negative pressure wound device comprising one or more integrated gas sensors for early detection and prediction of wound infection caused by pathogens such as bacteria and fungi.
[0108] Negative pressure wound devices are designed to continuously monitor wound healing and provide real-time data on the presence and levels of gases indicative of infection. This allows for timely intervention (such as wound cleaning, dressing changes, medications, etc.) to prevent or treat infection and improve overall wound healing outcomes.
[0109] One embodiment of the present invention relates to a negative pressure wound device that incorporates a gas sensor for continuous monitoring of wound healing and early detection of wound infections caused by pathogens such as bacteria and fungi. The negative pressure wound device includes a flexible wound dressing connected to a vacuum pump and a gas sensor system or module. The gas sensor module is configured to detect the presence of certain gases, such as hydrogen, oxygen, methane, carbon dioxide, ammonia, and volatile organic compounds (VOCs), which may indicate the presence of infection in a wound. The gas sensor module is also configured to detect the presence of specific gases produced by bacteria and fungi, enabling early detection and prediction of specific types of infection. The gas sensor module is connected to a control unit that analyzes gas levels and alerts caregivers when an infection is detected or predicted. The negative pressure wound device may also include a display for displaying gas sensor readings and may be configured to transmit the sensor readings to a remote device for analysis and / or storage. The device may be connected to a wireless communication system for transmitting the data to a remote monitoring system or healthcare provider. Integrating a gas sensor module into a negative pressure wound device enables real-time monitoring of wounds, allowing for early detection and prediction of wound infections, thereby improving patient care and treatment outcomes and helping to reduce antibiotic use.
[0110] In one embodiment, a negative pressure wound device includes a housing enclosing various components of the device, including a negative pressure source and a gas sensor. The negative pressure source applies negative pressure to the wound site, which helps remove excess fluid and promotes wound healing. The gas sensor is configured to measure the level of specific gases produced by bacteria and fungi in the wound. Data from the gas sensor is transmitted to a control unit configured to receive and analyze the data. The control unit is also responsible for controlling the negative pressure source based on the data from the gas sensor. For example, the negative pressure source can be activated based on a detected infection, and the suction rate can be adjusted based on the progression or resolution of the infection.
[0111] The device includes a flexible wound dressing connected to a vacuum pump and a gas sensor module. The gas sensor is housed within the device housing and can be of various types, including electrochemical, metal oxide, infrared, or optical.
[0112] The gas sensor is configured to detect the presence of gases such as hydrogen, oxygen, methane, carbon dioxide, ammonia, and volatile organic compounds (VOCs) in wound dressings that may indicate the presence of infection in the wound.VOCs include, but are not limited to, aldehydes, alcohols, ketones, acids, sulfur compounds, esters, hydrocarbons, and nitrogen compounds, propylene, acetaldehyde, ethanol, acetonitrile, (E)-2-butene, (Z)-2-butene, 2-propenal, n-propanol, acetone, 2-propanol, dimethyl sulfide, 1-pentene, isoprene, n-pentane, 1,3-dioxolane, 2-methyl-2-propenal, 2-methylpropanal, 3-butene-2-one, 2-methylfuran, n-butanal, 2-butanone, 3-methylfuran, ethyl acetate, 2-butenal, 2-methyl-1,3-dioxolane, 2-methyl-2-pentene, 2,3-dimethyl-2-butene, (E)-2-methyl-1,3-pentadiene, (Z)-2-methyl-1 ,3-pentadiene, 3-methylbutanal, 2-methylbutanal, isopropyl acetate, 2-pentanone, 2,5-dimethylfuran, allyl methyl sulfide, n-valeraldehyde, 3-methyl-2-butenal, 1-heptene, 2-heptene, n-heptane, 2-ethylbutanal, 4-methyl-3-penten-2-one, isobutyl acetate, 2-hexanone, n-hexanal, γ-butyrolactone, n-butyl acetate, (E)-2-hexenal, 1-octene, n-octane, 2-heptanone, n-heptanal, benzaldehyde, 1-nonene, n-nonane, 6-methyl-5-hepten-2-one, 2-pentylfuran, b-pinene, n-octanal, p-cymene, DL-limonene, styrene, eucalyptol, n-nonanal, 2-ethylhexanol, 3-methylhexane , butyraldehyde, ethylbenzene, ethyl butyrate, toluene, undecane, H2O, CO, NO, N2O, NO2, ammonia, acetophenone, 4-methylphenol, dodecane, dimethylpyrazine, 2-pentanol, 2-butanol, 2-pentene, 2-methylbutyl isobutyrate, 2-methoxy-5-methylthiophene, amyl isovalerate; 2-methylbutyl 2-methylbutyrate, 6-tridecane, 3-methyl 1H-pyrrole, 2-methyl-3-(2-propenyl)-pyrazine, 2,3-dimethyl-5-isopentylpyrazine, methyl thioacetate, methyl thiocyanate, hydrogen cyanide, 2-aminoacetophenone, 1-undecene, formaldehyde, dimethyl ether, carbon dioxide, pentafluoropropionamide, methylcyclohexane, 2-methylbutanol, N-propyl acetate, butyraldehyde, 2,5-Dimethyltetrahydrofuran, carbon disulfide, methyl propionate, methyl butyrate, 6-methyl-5-hepten-2-one, 2,5-dimethylpyrazine, hydrogen sulfide, propanol, indole, 1,1,2,2-tetrachloroethane, butanol, 2-tridecenone, 3-hydroxy-2-butanone, 1-hydroxy-2-propanone, 3-nitrobenzenesulfonic acid, 2-methylbutyl isobutyrate, 1,2-dimethylbenzene, 2-ethyl-1-hexanol, isopentyl 3-methylbutyrate, 2,4-dinitrobenzenesulfonic acid, decanal, 2-methyl-1-propanol, 2-phenylethanol, 1,4-dichlorobenzene, 2-methylbutyric acid, methyl mercaptan, 2-nonanone, 3-methyl-1-butanol, 3-methylbutyric acid, dimethyl trisulfide, dimethyl disulfide, and acetic acid.
[0113] In some other embodiments, one or more of the multiple sensor arrays include multiple physiological sensors, each of which is suitable for detecting at least one parameter selected from heart rate, pulse, respiratory rate, blood oxygen saturation, blood pressure, hydration level, pressure, posture and balance, body strain, neurological function, brain activity, blood pressure, intracranial pressure, auscultation information, skin temperature and body temperature, eye muscle movement, sleep, cholesterol, blood lipids, blood type, body fat density, muscle density, temperature, humidity and pressure.
[0114] Certain embodiments of the negative pressure wound device can measure skin and body temperature (-15°C to 45°C), heart rate, humidity (0-99%), and various concentrations of VOCs with detection limits ranging from 0.1 ppb to 5000 ppm, for example, 0.1-1 ppb, 1-5 ppb, 5-10 ppb, 10-50 ppb, 50-100 ppb, 100-200 ppb, 200-300 ppb, 300-500 ppb, 500 ppb-1 ppm, 1-2 ppm, 2-5 ppm, 5-10 ppm, 10-100 ppm, 100-200 ppm, 200-500 ppm, 500-1000 ppm, 1000-2000 ppm, and 2000-5000 ppm.
[0115] The gas sensor system is also configured to detect the presence of specific gases produced by bacteria and fungi, allowing for early detection and prediction of certain types of infection.
[0116] The negative pressure wound device may further include a display for displaying the results of the gas sensor readings and may be configured to transmit the sensor readings to a remote device for analysis and / or storage. The remote device may be configured to provide an indication of the type of wound infection and pathogen based on the analysis of the gas sensor readings.
[0117] The negative pressure wound device may also include a treatment module for taking timely intervention measures based on the data from the gas sensor to prevent or treat infection.
[0118] In one embodiment, the negative pressure wound device includes a housing with a wound dressing attached thereto. The shape and size of the housing can be adapted to the wound, and the wound dressing can be made of a porous material that allows gas to pass through.
[0119] The pump is in communication with the housing and is configured to apply negative pressure to the wound dressing. The pump may be a mechanical pump or an electric pump and may be powered by a battery or other power source.
[0120] The negative pressure wound device also includes a processor connected to the gas sensor system. The processor is configured to analyze data collected by the gas sensor system and issue an alarm if the data indicates the presence of a bacterial or fungal infection at the wound site. The alarm may be displayed on a display connected to the processor. The display may be a separate display unit or integrated into the negative pressure wound device.
[0121] The wound negative pressure device may also include a wireless communication module (such as a Bluetooth or WiFi system) for transmitting data from the gas sensor to a remote location for analysis and treatment recommendations. The battery provides power to the wound negative pressure device and the gas sensor.
[0122] In addition to the aforementioned features, the negative pressure wound device may also include a machine learning algorithm for analyzing gas sensor data to predict the likelihood of infection and recommend treatment options. The device may also include a database for storing and organizing gas sensor data, and a dashboard for displaying real-time data and issuing alerts when gas levels indicative of infection are detected. The device may also include a reporting module for generating reports on the gas sensor data and the effectiveness of therapeutic interventions.
[0123] The negative pressure wound device may further include a display screen for displaying the results of the gas sensor readings. The display screen may be a visual display screen, such as an LCD display screen, or an audio display screen, such as a speaker.
[0124] The negative pressure wound device may also include a transmitter for transmitting gas sensor readings to a remote device for analysis and / or storage. The remote device may be a computer, smartphone, or other internet-connected device.
[0125] During use, the negative pressure wound device is applied to the wound and the pump is activated to apply negative pressure to the wound dressing. A gas sensor detects the presence of gas in the wound dressing and transmits the sensor reading to a display and / or a remote device. The gas sensor readings can be used to determine the presence of wound infection and to indicate appropriate treatment options.
[0126] Integrating gas sensors into negative pressure wound devices can quickly and accurately detect wound infections, improving patient outcomes and reducing the risk of complications. The device is easy to use and provides continuous monitoring of wounds, allowing healthcare providers to address any potential infections promptly.
[0127] One embodiment of the present invention includes a system for early detection and prediction of wound infections caused by bacteria and fungi. The system includes a negative pressure wound device having a housing, a negative pressure source, and one or more gas sensors for detecting gases produced by bacteria and fungi present in the wound. The control unit is configured to receive data from the gas sensor and control the negative pressure source based on the data. The user interface displays the data from the gas sensor, and the treatment module takes timely intervention measures based on the data from the gas sensor to prevent or treat the infection. The communication module transmits the data from the gas sensor to a remote location for analysis and treatment recommendations. A machine learning algorithm can be used to analyze the data from the gas sensor to predict the possibility of infection and make treatment recommendations (such as cleaning the wound, changing the dressing, medication, etc.).
[0128] One embodiment of the present invention includes a method for early detection and prediction of wound infections caused by bacteria and fungi. One or more gas sensors integrated into a negative pressure wound device are used to continuously monitor the wound site. The levels of specific gases produced by bacteria and fungi present in the wound are measured, and real-time data on the presence and level of gases indicative of infection are provided to a control unit. The negative pressure applied by the negative pressure wound device can be adjusted based on the data from the gas sensor. The data from the gas sensor is displayed on a user interface. Timely intervention measures are taken based on the data from the gas sensor to prevent or treat the infection (such as cleaning the wound, changing the dressing, applying medication, etc.).
[0129] Reference Figure 12A and 12B Negative pressure wound device 1200 includes a housing 1205 with a wound dressing 1210 attached thereto. The wound dressing is made of a porous material to allow gas to pass through. A pump 1215 is in communication with the housing and is configured to apply negative pressure to the wound dressing. The pump can be a mechanical pump or an electric pump and can be powered by a battery or other power source.
[0130] Gas sensor 1220 is located within housing 1205 and is configured to detect gases present within wound dressing 1210. The gas sensor may include sensors for detecting hydrogen and methane, which may indicate the presence of anaerobic bacteria within the wound. The gas sensor may also include sensors for detecting other gases that may indicate wound infection. Housing 1205 is a container that holds wound dressing 1210 and gas sensor 1220. Gas sensor 1220 is located within housing 1205 and proximate to wound dressing 1210. This allows the sensor to detect gases produced by bacteria and fungi within the wound and provide real-time data regarding the presence and levels of gases indicative of infection.
[0131] Gas sensor 1220 communicates with a device processor, which is configured to process sensor readings and transmit the results to a display and / or transmitter of the device. The display can be a visual display, such as an LCD screen, or an audio display, such as a speaker. The user interface of the display can display real-time data on the gas levels detected by the sensor, as well as other relevant information, such as the type of bacteria or fungus present in the wound, and any recommended interventions or treatments.
[0132] The transmitter is configured to transmit sensor readings to a remote device 1230 for analysis (to determine wound infection) and / or storage. The remote device may be a computer, smartphone, or other device with internet connectivity. The gas sensors and other device components may be connected to the gas sensors and other components described above ( Figure 1 and Figure 2 The user interface of the remote device can display real-time data about gas levels detected by the sensor, as well as other relevant information such as the type of bacteria or fungus present in the wound and any recommended intervention or treatment.
[0133] Based on the information collected, including VOC patterns (and optionally vital signs and / or environmental conditions), machine learning algorithms (such as Naif Bayes, principal component analysis, multinomial logistic regression, and support vector machines) can be applied to train the data and generate correlations between certain infection issues and peak patterns (and optionally pump adjustments and / or treatment measures). Interventions and treatments can be tailored to the specific needs of the patient and the type of infection present in the wound. For example, if data from a gas sensor indicates the presence of anaerobic bacteria, interventions may include cleaning the wound and administering antibiotics that are effective against anaerobic bacteria. Alternatively, if the data indicates the presence of other types of bacteria or fungi, a different treatment plan may be recommended. Negative pressure wound devices can be designed to adjust the level of negative pressure based on the gas levels detected by the sensors. For example, if a gas sensor detects higher levels of hydrogen or methane gas (which may indicate the presence of anaerobic bacteria), the device can automatically increase the negative pressure level to help clear the bacteria and promote wound healing.
[0134] Once the model is established, using VOC patterns (and optionally vital signs and / or environmental conditions) as input, the system can generate early diagnostic results for wound infection (and optional pump adjustments, interventions and / or treatments).
[0135] In use, the negative pressure wound device 1200 is applied to the wound and the pump 1215 is started to apply negative pressure to the wound dressing 1210. The gas sensor 1220 detects the gas present in the wound dressing (in substantially the same manner as described above) and transmits the sensor reading to the processor. The processor processes the sensor reading in substantially the same manner as described above and transmits the result to the display and / or transmitter. The result of the gas sensor reading can be displayed on the display and / or transmitted to the remote device 1230 for analysis and storage. The result can be used to determine whether there is a wound infection and to prompt appropriate treatment. For example, the pump can be enabled based on the detected infection, the pump speed can be adjusted based on the progression or relief of the infection, etc. The wound negative pressure device with gas sensor can provide the same functions as described above. Figures 10A-10D Similar bacterial assays are shown.
[0136] Integrating gas sensors into negative pressure wound devices can quickly and accurately detect wound infections, improving patient outcomes and reducing the risk of complications. The device is easy to use and provides continuous monitoring of wounds, allowing healthcare providers to address any potential infections promptly.
[0137] In addition to hydrogen, methane, carbon dioxide, ammonia, and microbial VOCs, gas sensors can also be configured to detect other gases. Gas sensors can also be configured to detect multiple gases simultaneously or sequentially.
[0138] The negative pressure wound device may also include other sensors or monitoring systems, such as a temperature sensor or a pH sensor, to provide additional information about the wound environment. The device may also include a user interface, such as buttons or a touch screen, to allow the user to adjust the negative pressure or other device settings.
[0139] The negative pressure wound device may also include a wireless or wired connection to a remote device (such as a computer or smartphone) for transmitting gas sensor readings and other device data. The remote device may include software for analyzing the gas sensor readings and providing an indication of wound infection or other conditions. The remote device may also include a database for storing gas sensor readings and other device data for future reference or analysis.
[0140] The negative pressure wound device may further include a power source, such as a battery or an external power source, for powering the device and its components. The device may include a charging system, such as a USB port or a charging port, for charging the power source.
[0141] The negative pressure wound device may also include a waterproof or water-resistant housing or casing to protect the device and its components from moisture or other environmental factors. The housing or casing may also be sterilizable or disposable to reduce the risk of infection or contamination.
[0142] The negative pressure wound device may also include a timer or other tracking system to monitor the duration of treatment and prompt the user to change the wound dressing or other components as needed. The device may also include a memory or other storage system to store gas sensor readings and other device data for future reference or analysis.
[0143] Negative pressure wound devices may also include a user manual or other instructions to help users properly operate and maintain the device. These instructions may include information such as how to apply the device to a wound, how to activate and adjust negative pressure, and how to interpret gas sensor readings and other device data. The instructions may also include safety warnings and precautions to help users avoid injury or damage to the device.
[0144] Negative pressure wound devices may allow for continuous monitoring of wounds, enabling healthcare providers to promptly address any potential infection and improve patient outcomes.
[0145] Negative pressure wound devices can be designed and manufactured using a variety of materials and techniques to meet the needs and preferences of the user.
[0146] Wound dressings may be made of porous absorbent materials such as foam or gauze to allow the passage of gas and absorption of exudate.
[0147] Gas sensors can be made of sensitive and durable materials, such as semiconductors or metal oxides, to ensure accurate and reliable readings.
[0148] The pump can be made of durable and reliable materials such as metal or plastic to ensure long-lasting performance.
[0149] Negative pressure wound devices can also be designed to be user-friendly and easy to operate, with clear and intuitive controls and displays. The device can be ergonomically designed to fit comfortably over the wound and minimize the risk of user discomfort or irritation.
[0150] Negative pressure wound devices can also be designed to be compatible with a variety of wound dressings and other accessories (such as patches or wraps) to provide flexibility and customization. The device can also be compatible with various power sources (such as batteries or external power) for convenient and reliable operation.
[0151] In terms of manufacturing, negative pressure wound devices can be manufactured using a variety of techniques, such as injection molding, blow molding, or extrusion, to achieve the desired shape and size. Various quality control measures can also be applied to the device to ensure that it meets the necessary performance and safety standards.
[0152] Negative pressure wound devices may include, but are not limited to, housing components comprised of a chip system, a battery, an IoT module, a fan system of various shapes, and a port system. In some embodiments, such devices are connected to, but are not limited to, sterile tubing, capillary systems, breathable membranes, thin films, and plaster systems. These devices may include, but are not limited to, skin-safe adhesives, elastic bands, or combinations thereof, enabling attachment to any part of the human body.
[0153] In one embodiment of the negative pressure wound device, during operation, at least one of the one or more processors generates data by executing a method selected from the group consisting of: Naif Bayes, principal component analysis (PCA), support vector machine (SVM), multi-layer perception (MLP), generalized regression neural network (GRNN), fuzzy inference system (FIS), self-organizing map (SOM), radial bias function (RBF), genetic algorithm (GAS), neuro-fuzzy system (NFS), adaptive resonance theory (ART), partial least squares (PLS), multiple linear regression (MLR), principal component regression (PCR), discriminant function analysis (DFA), linear discriminant analysis (LDA), cluster analysis, and nearest neighbor analysis.
[0154] It will be appreciated that the embodiments described above and illustrated in the figures represent only a few implementations of embodiments for non-invasive detection of pathogens in wounds.
[0155] In some embodiments, detecting a gas mixture for a pathogen comprises exposing the gas mixture to a sensor array at an operating temperature of 250° C. or less, the sensor array comprising 2 to 6 to 8 to 12 to 32 or more sensors having a sensing material, wherein each sensor comprises at least one or two or more or a mixture of nanoporous structures, such as mesoporous, macroporous, microporous, nanoporous, non-porous, hierarchically porous materials, including mesoporous / macroporous hierarchical structures, microporous / macroporous hierarchical structures, microporous / mesoporous hierarchical structures, microporous / mesoporous / macroporous hierarchical structures, and the like. The configuration of the mesoporous structure is selected from an ordered mesoporous structure with regular pore arrangement, a worm-like mesoporous structure with uniform pore size but no long-range regularity, or a disordered mesoporous structure with a pore size of 2-50 nm. The configuration of the macroporous structure is selected from an ordered macroporous structure with a pore size between 50 nm and 50 μm or a disordered macroporous structure. In another embodiment, the sensor material has a pore size range of 0.4 to 2 nm, 2 to 50 nm, 50 to 200 nm, 200 to 500 nm, 500 nm to 1 μm, 1 to 50 μm. The specific surface area is 1-1000 m 2 / g.
[0156] In some embodiments, the sensing material comprises a mono-, di-, ternary, quaternary, penta-, hexa-, hepta-, and octa-component metal oxide selected from the group consisting of tin (Sn), terbium (Tb), cobalt (Co), zinc (Zn), indium (In), copper (Cu), nickel (Ni), chromium (Cr), manganese (Mn), tungsten (W), titanium (Ti), vanadium (V), iron (Fe), aluminum (Al), gallium (Ga), silver (Ag), gold (Au), palladium (Pd), rhodium (Rh), ruthenium (Ru), molybdenum (Mo), niobium (Nb), zirconium (Zr), yttrium (Y), lanthanum (T), tungsten (W), tungsten (W), tungsten (W), tungsten (W), tungsten (T ... (La), platinum (Pt), silicon (Si), cerium (Ce) and tellurium (Te), such as CoZnInSnOx, CuSnCoInOx, CoZnCrNiOx, SnTbCoOx, SnTbZnOx, CoTbInOx, CoNiTbOx, CoCeNiCuOx, ZnSnTeOx, CoZnInOx, CuSnInOx, CoCrNiOx, SnWLaOx, SnInLaCoOx, CoOx, CoTbOx, where the composition of each chemical element is different and x=0.01-1.
[0157] In some embodiments, a set of detected sensor array signals may be obtained based on a change in resistance of the sensing material.
[0158] The methods of some embodiments may include exposing the sensor array to a gas mixture produced by pathogens of a wound infection. As used herein, the gas mixture may include VOCs or vapors from a subject, for example, from the subject's skin or breath. In some cases, the VOCs or vapors are released from the subject's skin. The skin can be skin on any wound site of the subject, for example, the subject's palm, fingers, arm, leg, back, abdomen, or foot. In some examples, the gas mixture includes various odorous chemical classes, such as aldehydes, alcohols, ketones, acids, sulfur-containing compounds, esters, hydrocarbons, and nitrogen-containing compounds.
[0159] The methods of some embodiments can be performed at relatively low operating temperatures. In some embodiments, the operating temperature can be at most 250°C, at most 2000°C, at most 1500°C, at most 1000°C, at most 80°C, at most 60°C, at most 50°C, at most 40°C, at most 30°C, at most 20°C, or at most 10°C. In some examples, the operating temperature can be in the range of about -30°C to about 40°C, for example, about 0°C to 30°C, about 10°C to about 30°C, or about 20°C to about 25°C. In some examples, the operating temperature can be 50°C or lower.
[0160] The methods, gas sensors, and devices of some embodiments can detect relative levels of a gas mixture. In some cases, the methods and devices of some embodiments can detect VOCs in a gas mixture at concentrations of 5000 ppm or less, 4000 ppm or less, 3000 ppm or less, 2000 ppm or less, 1000 ppm or less, 500 ppm or less, 250 ppm or less, 100 ppm or less, 50 ppm or less, 10 ppm or less, 1 ppm or less, 800 ppb or less, 600 ppb or less, 500 ppb or less, 400 ppb or less, 200 ppb or less, 100 ppb or less, 80 ppb or less, 60 ppb or less, 40 ppb or less, 20 ppb or less, 10 ppb or less, and 1 ppb or less. In some cases, the methods, sensors, and devices of some embodiments can be configured to have a detection limit for gases at 5000 ppm or less in a gas mixture. The term "detection limit" refers to the lowest amount of a substance that can be distinguished from the absence of a substance (e.g., a blank value). In some cases, some embodiments of the gas sensor or device are configured to have a detection limit of 1000 ppm or less, 500 ppm or less, such as 400 ppm or less, including 300 ppm or less, 200 ppm or less, 100 ppm or less, 75 ppm or less, 50 ppm or less, 25 ppm or less, 20 ppm or less, 15 ppm or less, 10 ppm or less, 5 ppm or less, 1 ppm or less, 500 ppb or less, 100 ppb or less, 50 ppb or less, 10 ppb or less, or 1 ppb or less. In some cases, some embodiments of the gas sensor or device are configured to have a detection limit of 1 ppm or less. In some cases, the gas sensor or device is configured to detect at least 1 ppb, at least 10 ppb, at least 50 ppb, at least 100 ppb, at least 500 ppb, at least 1 ppm, at least 5 ppm, at least 10 ppm, at least 15 ppm, at least 20 ppm, at least 25 ppm, at least 50 ppm, at least 75 ppm, at least 100 ppm, or at least 200 ppm of VOCs.
[0161] In some embodiments, the sensor array can detect gas mixtures that contain or have accumulated volatile compounds, as well as gas mixtures that do not contain or have accumulated volatile compounds.
[0162] The subject can be an animal, including a mammal, preferably a human, to which the methods of some embodiments can be applied. Species of mammals that may benefit from embodiments of the present invention include, but are not limited to, apes, chimpanzees, orangutans, humans, and monkeys; domesticated animals (e.g., pets) such as dogs, cats, guinea pigs, and hamsters; and large domesticated animals such as cattle, horses, goats, and sheep. Furthermore, the subject can be any wild animal, as embodiments of the present invention can also be used for tracking purposes.
[0163] In some embodiments, bacterial identification can be based on detecting volatile organic or inorganic compounds obtained from pathogens in a wound infection of a subject using a sensor array. A sensor array is any device capable of generating an electrical signal that changes in response to interaction with the volatile compounds of interest. A sensor signal can be any observable change in one or more quantifiable entities (e.g., resistance, voltage, frequency, etc.).
[0164] In some embodiments, the reference signal includes known pathogens, such as bacteria and fungi. The reference signal can be established using standard samples obtained from in vitro cultured pathogens or from infected and uninfected patients or animals, which are evaluated using embodiments of the present invention and / or traditional methods to identify the pathogens therein.
[0165] The data acquisition unit may include a nanosensor, a biosensor, a readout circuit, one or more microcontrollers (such as signal converters, signal processing, control circuits, power control integrated circuits, etc.), a communication unit and a battery.
[0166] In some embodiments, the devices of some embodiments include one or more of the following functions or attributes: skin temperature and body temperature (-15°C to 45°C), heart rate, humidity (0-99%), VOC concentration (1ppb-5000ppm), providing sound alarms and silent alarms or color alarms or other visual information or notifications when pathogens are detected, and can be directly integrated into existing products (such as wound dressing systems, wound healing systems, wound management systems).
[0167] Some embodiments of the device include one or more of the aforementioned gas sensors. In some embodiments, the device further includes a power supply, a display, a computer, a microcontroller unit, a readout circuit, a communication module (e.g., a wireless communication module), a memory, or any combination thereof. The gas sensor and / or device can detect and differentiate between two or more pathogens (e.g., bacteria, fungi, etc.) in a polymicrobial infection based on the pattern of changes in the properties of the sensing material.
[0168] The device in some embodiments can be standalone and / or integrated into (e.g., as part of) and / or interoperable with an interactive mobile device or application with Internet of Things (IoT) capabilities. In some embodiments, the device can be integrated into or as part of a professional wound dressing system, a cryogenic bag, a transport chamber, a smartphone, a wearable device, a healthcare device, a medical device, a fitness device (e.g., a treadmill, an elliptical trainer, etc.), or a combination thereof. The device can detect VOCs, such as those emitted from the breath or the skin (e.g., the skin of the subject's hands, fingers, ears, nose, face, eyes, arms, legs, chest, breast, back, abdomen, or feet).
[0169] The devices in some embodiments can be wearable devices. In some cases, using the sensing materials of the present invention, a gas sensor array sensitive to VOCs released by wound infection pathogens can be fabricated into a wearable device. Examples of wearable devices include armbands, sleeves, jackets, glasses, eye masks, goggles, gloves, watches, wristbands, bracelets, earbuds, headphones, clothing, hats, headbands, earphones, bras, and jewelry.
[0170] The devices in some embodiments can be portable. In some cases, using the sensing materials of the present invention, a gas sensor array sensitive to VOCs released by wound infection pathogens can be deposited into a portable device. Examples of portable devices include keychains and breathalyzers.
[0171] The device in some embodiments may be a disposable device (eg, a wound dressing, etc.), wherein the disposable device (and one or more sensors) is configured for one-time use and can be replaced after each use.
[0172] The devices of some embodiments may have relatively low power consumption. For example, the devices of some embodiments may have a power consumption of at most 500 μA, at most 400 μA, at most 300 μA, at most 200 μA, at most 20 μA, at most 10 μA, at most 9 μA, at most 8 μA, at most 7 μA, at most 6 μA, at most 5 μA, at most 4 μA, at most 3 μA, at most 2 μA, or at most 1 μA.
[0173] The volume of the device in some embodiments may be relatively small. For example, the volume of the device may be at most 300 cm 3 , up to 200cm 3 , up to 100cm 3 , up to 30cm 3 , up to 20cm 3 , up to 15cm 3 , up to 10cm 3 , up to 8cm 3 , up to 6cm3 , up to 5cm 3 , up to 4cm 3 , up to 3cm 3 , up to 2cm 3 , or at most 1cm 3 .
[0174] In some cases, the device in certain embodiments is intelligent. For example, the device can be configured to be calibrated (e.g., self-calibrated). Calibration can be performed based on specific reference information for a single user.
[0175] The device in some embodiments may be configured to read VOC concentrations digitally. The device may convert a signal from one form to another. For example, the device may convert an analog signal to a digital signal and / or convert a digital signal to a measurement of the user's energy consumption and / or metabolic profile.
[0176] The device in some embodiments can transmit data wirelessly, for example, via the internet, Bluetooth, Bluetooth Low Energy (BLE), or a combination thereof. The device can be configured to connect to a smartphone or computer (e.g., a laptop) to visualize, monitor, and / or analyze infection development and progression, antibiotic treatment, metabolic profile, and physiological status, or a combination thereof, of a subject using (e.g., wearing) the device.
[0177] Data from the device of some embodiments may be shared with medical professionals in real time to enable more accurate and appropriate treatment.
[0178] Device (such as Figure 1 、 Figure 6A 、 Figure 6B 、 Figure 8 、 Figure 11 、 Figure 12A and Figure 12B ) can determine the above-mentioned interventions and / or treatments. Based on the collected information, including VOC patterns (and optionally vital signs and / or environmental conditions), machine learning algorithms (such as Nye's Bayes, principal component analysis, multinomial logistic regression, and support vector machines) can be applied in embodiments to train the data and generate correlations between certain infection problems and peak patterns (and optionally interventions, stressor control, and / or treatments). Once the model is established, using VOC patterns (and optionally vital signs and / or environmental conditions) as input, the system can generate early diagnostic results for wound infection (and optionally stressor adjustments, interventions, and / or treatments).
[0179] The device of some embodiments can continuously detect the presence of wound infection. For example, the device of some embodiments can monitor the growth process of pathogens from incubation, colonization to infection in real time.
[0180] In some embodiments, the one or more pathogens include at least one of bacteria and fungi. Bacteria may include: Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, Enterococcus faecium, Clostridium difficile, Campylobacter jejuni, Listeria monocytogenes, Vibrio cholerae, Vibrio parahaemolyticus, Mycobacterium tuberculosis, Mycobacterium leprae, Helicobacter pylori, Bordetella pertussis, Legionella pneumophila, Shigella, Yersinia pestis, Francisella tularensis, Brucella, Borrelia burgdorferi, Chlamydia trachomatis, Chlamydia pneumoniae, Cook's fever bacillus, Rickettsia rickettsii, Rickettsia prowazekii, Bartonella henselae, Burkholderia pseudomallei, Burkholderia mallei, Acinetobacter baumannii , Moraxella catarrhalis, Nocardia, Propionibacterium acnes, Actinomyces, Treponema pallidum, Treponema denticola, Clostridium, Porphyromonas, Prevotella, Bacteroides fragilis, Bacteroides multiforme, Capnocytophaga, Pasteurella multocida, Actinomyces, Streptobacillus moniliformis, Erysipelothrix rhusiopathiae, Lactobacillus, Corynebacterium diphtheriae, Corynebacterium jejuni, Nocardia asteroides, Mycoplasma pneumoniae, Ureaplasma urealyticum, Legionella Longbeach, Legionella Bozeman, Legionella Dumo, Legionella Mikdad, Legionella Anissa, Legionella Fischbach, Legionella Gorman, Legionella Jordan, Legionella London, Legionella Ma, Legionella Oak Ridge, Legionella Cauterina, Legionella rubrum, Legionella Herron Moor, Legionella Stegelwater, Legionella Taurin and Legionella Worsworth.
[0181] Fungi may include Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Epidermophyton floccosum, Pneumocystis jiroveci, Fusarium solani, Fusarium oxysporum, Rhizopus, Mucor, Scedosporium multiflorum, Sporothrix schenckii, Paracoccidioides brasiliensis, Candida dubliniensis, Candida portugalensis, Candida guillimonensis, Candida kefir, Candida anonymum, Candida lipolytica, Candida utilis, Candida foetida, Candida rugosa, Candida norvegicus, Candida pellicularis, Candida sakei, Candida asteroides, Candida fasciata, Aspergillus flavus, Aspergillus niger, Aspergillus terreus, and Ximulong Candida, Candida pseudoglabrata, Candida auris, Trichosporon arguta, Trichosporon chei, Trichosporon viscidus, Trichosporon ovata, Trichosporon asteroidea, Geotrichum candidum, Geotrichum capitulum, Paecilomyces spp., Acremonium spp., Alternaria spp., Cladosporium spp., Penicillium spp., Aspergillus nidulans, Aspergillus versicolor, Exophiala dermatitidis, Exophiala zhenni, Exophiala spinosa, Exophiala xenopoda, Candida utilis var., Candida glabrata var., Trichosporon doha, Trichosporon domestica, Trichosporon japonicum, Trichosporon moniliformis, Trichosporon viscidus, Trichosporon brucei, Rhizomucor pusillus, Rhizomucor variabilis, Cunninghamella brazilica, Cunninghamella spinulosa, Cunninghamella shortspinosa, Absidia corymbifera, Mucor circinelloides, Mucor racemosus, Trichoderma variabilis, Koji microsporum, and Rhizopus spp.
[0182] It will be apparent to those skilled in the art that various modifications and variations of the methods, pharmaceutical compositions, and kits described herein can be made without departing from the scope and spirit of the present disclosure. Although the present disclosure has been described in conjunction with specific embodiments, it will be understood that the present disclosure can be further modified and that the present disclosure should not be unduly limited to these specific embodiments. In fact, various modifications of the modes for implementing the present disclosure that are apparent to those skilled in the art fall within the scope of the present disclosure. This application is intended to cover any variations, uses, or improvements of the present disclosure that generally follow the principles of the present disclosure and include deviations from the present disclosure in conventional practices known in the art to which the present disclosure belongs, and that can be applied to the basic features described herein without further elaboration.
Claims
1. A method for detecting wound infection, comprising: receiving information related to detection of one or more gases emitted by one or more pathogens causing infection in a wound from at least one sensor, wherein the at least one sensor includes a sensing material that changes one or more properties in response to the presence of the one or more gases; and Information from the at least one sensor is analyzed by at least one processor to identify the one or more pathogens and determine whether an infection is present in the wound, wherein the one or more pathogens are identified based on a pattern of changes in the one or more characteristics indicative of the respective pathogens.
2. The method according to claim 1, wherein The at least one sensor further provides measurements of one or more of a set of physiological parameters and environmental conditions, and analyzing the information includes: The information and measurements from the at least one sensor are analyzed to identify the one or more pathogens and determine whether an infection is present in the wound, wherein the one or more pathogens are identified based on the pattern of changes in the one or more characteristics indicative of the respective pathogens and the measurements.
3. The method according to claim 1, wherein The one or more pathogens include two or more pathogens selected from bacteria and fungi, and the method further comprises: Detecting and differentiating the two or more pathogens in a polymicrobial infection.
4. The method according to claim 1, wherein Analytical information includes: The information is analyzed by a machine learning model to correlate patterns of change in the one or more characteristics with patterns of corresponding pathogens.
5. The method according to claim 1, wherein The at least one sensor is disposed within one of a wearable device, a portable device, a disposable device, and a wound dressing, the method further comprising: Monitor the growth of pathogens from incubation, colonization to infection in real time.
6. The method according to claim 1, wherein The at least one sensor is further configured to differentiate between two or more pathogens in a polymicrobial infection.
7. The method according to claim 1, wherein The information of the at least one sensor is monitored in real time.
8. The method according to claim 1, wherein The at least one sensor is disposed within a wound dressing, and the wound dressing and the at least one sensor are configured for single use.
9. The method according to claim 1, wherein The one or more properties of the sensing material that change include conductivity, capacitance, resistance, or impedance.
10. The method according to claim 1, wherein Also included is providing an alert or notification to a healthcare provider or patient based on information from the at least one sensor.
11. The method according to claim 1, wherein The one or more pathogens include at least one of bacteria and fungi, and the analyzing further includes identifying the one or more pathogens based on a pattern of changes in the one or more characteristics corresponding to the bacteria and fungi.
12. The method according to claim 1, wherein The one or more pathogens include at least one of bacteria and fungi, wherein the bacteria include Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, Enterococcus faecium, Clostridium difficile, Campylobacter jejuni, Listeria monocytogenes, Vibrio cholerae, Vibrio parahaemolyticus, Mycobacterium tuberculosis, Mycobacterium leprae, Helicobacter pylori, Bordetella pertussis, Legionella pneumophila, Shigella, Yersinia pestis, Francisella tularensis, Brucella, Borrelia burgdorferi, Chlamydia trachomatis, Chlamydia pneumoniae, Cook's fever bacillus, Rickettsia rickettsii, Rickettsia prowazekii, Bartonella henselae, Burkholderia pseudomallei, Burkholderia pseudomallei, Burkholderia mallei, Burkholderia pseudomallei ... Kerholderia, Acinetobacter baumannii, Moraxella catarrhalis, Nocardia, Propionibacterium acnes, Actinomyces, Treponema pallidum, Treponema denticola, Clostridium, Porphyromonas, Prevotella, Bacteroides fragilis, Bacteroides multiforme, Capnocytophaga, Pasteurella multocida, Actinomyces, Streptobacillus moniliformis, Erysipelothrix rhusiopathiae, Lactobacillus, Corynebacterium diphtheriae, Corynebacterium jejuni, Nocardia asteroides, Mycoplasma pneumoniae, Ureaplasma urealyticum, Legionella Longbeach, Legionella Bozeman, Legionella Dumo, Legionella Mikdad, Legionella Anissa, Legionella Fischbach, Legionella Gorman, Legionella Jordan, Legionella London, Legionella Ma, Legionella Oak Ridge, Legionella Cauterina, Legionella rubrum, Legionella Herron Heath, Legionella Stegelwater, Legionella Taurin and Legionella Worsworth,The fungi include Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Epidermophyton floccosum, Pneumocystis jiroveci, Fusarium solani, Fusarium oxysporum, Rhizopus, Mucor, Scedosporium multiflorum, Sporothrix schenckii, Paracoccidioides brasiliensis, Candida dubliniensis, Candida portugalensis, Candida guillimonensis, Candida kefir, Candida anonymum, Candida lipolytica, Candida utilis, Candida foetida, Candida rugosa, Candida norvegicus, Candida pellicle, Candida sakei, Candida asteroidea, Candida fasciata, Aspergillus flavus, Aspergillus niger, Aspergillus terreus, and Candida shigellae. Candida dragon, Candida pseudoglabrata, Candida variegata, Candida auris, Trichosporon arguta, Trichosporon chei, Trichosporon viscidus, Trichosporon ovata, Trichosporon asteroidea, Geotrichum candidum, Geotrichum capitulum, Paecilomyces spp., Acremonium spp., Alternaria spp., Cladosporium spp., Penicillium spp., Aspergillus nidulans, Aspergillus versicolor, Exophiala dermatitidis, Exophiala zhenni, Exophiala spinosa, Exophiala xenopoda, Candida utilis var., Candida glabrata var., Trichosporon doha, Trichosporon familiaris, Trichosporon japonicum, Trichosporon moniliformis, Trichosporon viscidus, Trichosporon brucei, Rhizomucor microti, Rhizomucor multivariate, Cunninghamella brazilica, Cunninghamella spinulosa, Cunninghamella shortspinosa, Absidia corymbifera, Mucor circinelliformis, Mucor racemosus, Mucor multivariate, Koji microsporum, and Rhizopus spp.
13. The method according to claim 1, wherein The at least one sensor is disposed within the wound dressing, the method further comprising: Negative pressure is applied to the wound through a negative pressure source to promote wound healing.
14. The method according to claim 13, wherein Also includes: The rate of the negative pressure source is adjusted based on information from the at least one sensor.
15. The method according to claim 1, wherein Also includes: A treatment method for the wound is determined by the at least one processor based on information from the at least one sensor.
16. A system for detecting wound infection, comprising: at least one sensor for detecting one or more gases emitted by one or more infection-causing pathogens in the wound, wherein the at least one sensor comprises a sensing material that changes one or more properties in response to the presence of the one or more gases; as well as At least one processor is configured to analyze information from the at least one sensor to identify the one or more pathogens and determine whether an infection is present in the wound, wherein the one or more pathogens are identified based on a pattern of changes in the one or more characteristics indicative of the respective pathogens.
17. The system according to claim 16, wherein: The at least one sensor further provides measurements of one or more of a set of physiological parameters and environmental conditions, and analyzing the information includes: The information and measurements from the at least one sensor are analyzed to identify the one or more pathogens and determine whether an infection is present in the wound, wherein the one or more pathogens are identified based on the pattern of changes in the one or more characteristics indicative of the respective pathogens and the measurements.
18. The system of claim 16 , wherein the one or more pathogens comprise at least one of bacteria and fungi, wherein the bacteria comprise Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, Enterococcus faecium, Clostridium difficile, Campylobacter jejuni, Listeria monocytogenes, Vibrio cholerae, Vibrio parahaemolyticus, Mycobacterium tuberculosis, Mycobacterium leprae, Helicobacter pylori, Bordetella pertussis, Legionella pneumophila, Shigella, Yersinia pestis, Francisella tularensis, Brucella, Borrelia burgdorferi, Chlamydia trachomatis, Chlamydia pneumoniae, Cook's fever bacillus, Rickettsia rickettsii, Rickettsia prowazekii, Bartonella henselae, and Burkholderia pseudomallei. Klebsiella, Burkholderia mallei, Acinetobacter baumannii, Moraxella catarrhalis, Nocardia, Propionibacterium acnes, Actinomyces, Treponema pallidum, Treponema denticola, Clostridium, Porphyromonas, Prevotella, Bacteroides fragilis, Bacteroides multiforme, Capnocytophaga, Pasteurella multocida, Actinomyces, Streptobacillus moniliformis, Erysipelothrix rhusiopathiae, Lactobacillus, Corynebacterium diphtheriae, Corynebacterium jejuni, Nocardia asteroides, Mycoplasma pneumoniae, Ureaplasma urealyticum, Legionella Longbeach, Legionella Bozeman, Legionella Dumo, Legionella Mikdad, Legionella Anissa, Legionella Fischbach, Legionella Gorman, Legionella Jordan, Legionella London, Legionella Ma, Legionella Oak Ridge, Legionella Cauterina, Legionella rubrum, Legionella Herron Moor, Legionella Stegelwater, Legionella Taurin and Legionella Worsworth,The fungi include Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Epidermophyton floccosum, Pneumocystis jiroveci, Fusarium solani, Fusarium oxysporum, Rhizopus, Mucor, Scedosporium multiflorum, Sporothrix schenckii, Paracoccidioides brasiliensis, Candida dubliniensis, Candida portugalensis, Candida guillimonensis, Candida kefir, Candida anonymum, Candida lipolytica, Candida utilis, Candida foetida, Candida rugosa, Candida norvegicus, Candida pellicle, Candida sakei, Candida asteroidea, Candida fasciata, Aspergillus flavus, Aspergillus niger, Aspergillus terreus, and Candida shigellae. Candida dragon, Candida pseudoglabrata, Candida variegata, Candida auris, Trichosporon arguta, Trichosporon chei, Trichosporon viscidus, Trichosporon ovata, Trichosporon asteroidea, Geotrichum candidum, Geotrichum capitulum, Paecilomyces spp., Acremonium spp., Alternaria spp., Cladosporium spp., Penicillium spp., Aspergillus nidulans, Aspergillus versicolor, Exophiala dermatitidis, Exophiala zhenni, Exophiala spinosa, Exophiala xenopoda, Candida utilis var., Candida glabrata var., Trichosporon doha, Trichosporon familiaris, Trichosporon japonicum, Trichosporon moniliformis, Trichosporon viscidus, Trichosporon brucei, Rhizomucor microti, Rhizomucor multivariate, Cunninghamella brazilica, Cunninghamella spinulosa, Cunninghamella shortspinosa, Absidia corymbifera, Mucor circinelliformis, Mucor racemosus, Mucor multivariate, Koji microsporum, and Rhizopus spp.
19. The system according to claim 16, wherein: Analytical information includes: The information is analyzed by a machine learning model to correlate patterns of change in the one or more characteristics with patterns of corresponding pathogens.
20. The system of claim 16, wherein: The at least one sensor is disposed within one of a wearable device, a portable device, a disposable device, and a wound dressing.
21. The system of claim 20, wherein: The at least one processor is disposed in a remote device.
22. The system of claim 20, wherein: The at least one sensor is disposed within the wound dressing, the system further comprising: A negative pressure source is used to apply negative pressure to the wound to promote healing.
23. The system of claim 22, wherein: The at least one processor is further configured to: The rate of the negative pressure source is adjusted based on information from the at least one sensor.
24. The system of claim 16, wherein: The at least one processor is further configured to: A treatment method for the wound is determined based on information from the at least one sensor.
25. An apparatus comprising: A storage device containing software, the software being executed by at least one processor, enabling the at least one processor to: receiving information related to detection of one or more gases emitted by one or more pathogens causing infection in a wound from at least one sensor, wherein the at least one sensor includes a sensing material that changes one or more properties in response to the presence of the one or more gases; and Information from the at least one sensor is analyzed to identify the one or more pathogens and determine whether an infection is present in the wound, wherein the one or more pathogens are identified based on a pattern of changes in the one or more characteristics indicative of the respective pathogens.
26. The device according to claim 25, wherein The one or more pathogens include at least one of bacteria and fungi, and the analysis information includes: The information is analyzed by a machine learning model to correlate patterns of change in the one or more characteristics with patterns of corresponding pathogens.
27. The apparatus according to claim 25, wherein A negative pressure source applies negative pressure to the wound to promote healing, the software further causing the at least one processor to: The rate of the negative pressure source is adjusted based on information from the at least one sensor.
28. The apparatus according to claim 25, wherein The software further causes the at least one processor to: A treatment method for the wound is determined based on information from the at least one sensor.
